Literature DB >> 8877577

Social support and adherence behavior among women with abnormal Pap smears.

L A Crane1.   

Abstract

BACKGROUND: Studies of hypertension, diabetes, and diet have indicated a relationship between social support and adherence to treatment regimens. Estimates of nonadherence following abnormal Pap test results range as high as 40%. In this study, the relationship between social support and adherence behavior was examined in a population of low-income, public-health-department patients with abnormal Pap smears.
METHODS: Medical record reviews ascertained adherence behavior and interviews determined receipt of social support for 498 women.
RESULTS: Related to adherence were: receipt of any social support; receipt of each of three types of support (informational, emotional, and tangible support); amount of support received; satisfaction with support; and source of support. Reported need for support was not related to adherence behavior. Receipt of social support was more strongly related to adherence when the woman's emotional response to the notification of the abnormal Pap smear was greater, and when acculturation was higher (among Latinas). Knowledge of the results of the Pap test was found to be an intervening variable between receipt of informational support and adherence. Knowledge of the purpose of the Pap smear was found to be independently related to adherence. Among black women, emotional support was most strongly related to adherence, while among Latinas, tangible support was most strongly related to adherence. In a multivariate model, Pap-test knowledge and the interaction between emotional response and receipt of any social support were significantly related to adherence.
CONCLUSIONS: Findings suggest that supportive interventions, including provision of medical information, emotional support, child care, and transportation, could help to reduce nonadherence.

Entities:  

Mesh:

Year:  1996        PMID: 8877577     DOI: 10.1080/08858199609528421

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  7 in total

1.  Comparison of human papillomavirus DNA testing and repeat Papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. HPV Effectiveness in Lowgrade Paps (HELP) Study No. 1 Group.

Authors:  A Lytwyn; J W Sellors; J B Mahony; D Daya; W Chapman; N Ellis; P Roth; A T Lorincz; A Gafni
Journal:  CMAJ       Date:  2000-09-19       Impact factor: 8.262

Review 2.  Interventions to improve follow-up of abnormal findings in cancer screening.

Authors:  Roshan Bastani; K Robin Yabroff; Ronald E Myers; Beth Glenn
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

3.  Psychosocial barriers to follow-up adherence after an abnormal cervical cytology test result among low-income, inner-city women.

Authors:  Siu-Kuen Azor Hui; Suzanne M Miller; Kuang-Yi Wen; Zhu Fang; Tianyu Li; Joanne Buzaglo; Enrique Hernandez
Journal:  J Prim Care Community Health       Date:  2014-04-09

4.  Cancer stage knowledge and desire for information: mismatch in Latino cancer patients?

Authors:  Rosario Costas-Muniz; Rohini Sen; Jennifer Leng; Abraham Aragones; Julia Ramirez; Francesca Gany
Journal:  J Cancer Educ       Date:  2013-09       Impact factor: 2.037

5.  Health Beliefs Associated with the Follow-Up of Pap Smear Abnormalities Among Low-Income Women in Medellín, Colombia.

Authors:  Isabel Cristina Garcés-Palacio; Sara Milena Ramos-Jaraba; Diana Carolina Rubio-León
Journal:  J Cancer Educ       Date:  2018-04       Impact factor: 2.037

6.  Effect of health beliefs on delays in care for abnormal cervical cytology in a multi-ethnic population.

Authors:  Karin Nelson; Ann M Geiger; Carol M Mangione
Journal:  J Gen Intern Med       Date:  2002-09       Impact factor: 5.128

7.  Peer navigation improves diagnostic follow-up after breast cancer screening among Korean American women: results of a randomized trial.

Authors:  Annette E Maxwell; Angela M Jo; Catherine M Crespi; Madhuri Sudan; Roshan Bastani
Journal:  Cancer Causes Control       Date:  2010-07-31       Impact factor: 2.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.